Viewing StudyNCT03423199



Ignite Creation Date: 2024-05-06 @ 11:03 AM
Last Modification Date: 2024-10-26 @ 12:39 PM
Study NCT ID: NCT03423199
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-22
First Post: 2018-01-09

Brief Title: PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive HER2-negative Advanced Breast Cancer Women - Asian studY
Sponsor: National Cancer Center Japan
Organization: National Cancer Center Japan

Conditions & Keywords Data

Conditions:
Name
Breast Neoplasms
Keywords:
Name View
metastatic View
breast Cancer View
palbociclib PD-0332991 View
tamoxifen View
goserelin View
any menopausal status View
hormone receptor positive View
HER2 negative View
locally advanced View